Skip to content

Drug interactions

Dabigatran etexilate + Epoprostenol

Severity: Moderate

Dabigatran etexilate and Epoprostenol: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Epoprostenol inhibits platelet aggregation, so combining it with an anticoagulant such as dabigatran adds to bleeding tendency. The clinical risk is greatest in patients with other bleeding risk factors.

What this interaction means in plain words

Dabigatran etexilate and Epoprostenol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dabigatran etexilate belongs to Cardiovascular; Epoprostenol belongs to Genitourinary.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic effect: platelet inhibition by epoprostenol plus thrombin inhibition by dabigatran.

What to do

Monitor for signs of bleeding and check hemoglobin periodically. Reassess the need for both drugs if bleeding occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dabigatran etexilate and Epoprostenol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dabigatran etexilate with Epoprostenol?

MediHelp rates the interaction as moderate. Dabigatran etexilate and Epoprostenol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Epoprostenol inhibits platelet aggregation, so combining it with an anticoagulant such as dabigatran adds to bleeding tendency. The clinical risk is greatest in patients with other bleeding risk factors.

How serious is the interaction between Dabigatran etexilate and Epoprostenol?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for signs of bleeding and check hemoglobin periodically. Reassess the need for both drugs if bleeding occurs.

What other medicines interact with Dabigatran etexilate?

MediHelp also lists interactions of Dabigatran etexilate with, for example, Defibrotide, Ketorolac, Mifepristone. The full list is on the Dabigatran etexilate page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in